Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Intravenous Lidocaine on Serum THBS2, MMPS and VEGF-C in Patients Undergoing Radical Hyterectomy Surgery After General Anesthesia

NCT05560035 is registered in ClinicalTrials.gov with General Hospital of Ningxia Medical University as lead sponsor.

NCT NCT05560035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05560035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Intravenous Lidocaine on Serum THBS2, MMPS and VEGF-C in Patients Undergoing Radical Hyterectomy Surgery After General Anesthesia
Lead sponsor
General Hospital of Ningxia Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2022
Completion date
December 1, 2024
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, metastatic cancer